BI-RADS 2 Follow-Up Recommendations
For women ≥40 years with BI-RADS 2 (benign findings) on mammography, return to routine annual screening mammography—no additional imaging or short-interval follow-up is required. 1
Understanding BI-RADS 2 Classification
BI-RADS Category 2 represents definitively benign findings with essentially zero malignancy risk. 1, 2 These findings include:
- Calcifying fibroadenomas
- Oil cysts and lipomas
- Intramammary lymph nodes
- Vascular calcifications
- Implants
- Architectural distortion clearly related to prior surgery 1
A large retrospective study of 192 patients with BI-RADS 2 lesions confirmed 0% malignancy rate with follow-up ranging 2-9 years, demonstrating that breast biopsies are unnecessary in these cases. 2
Management Algorithm
Resume routine screening: Return to annual screening mammography in 1 year. 1, 3
No additional workup needed: Short-interval follow-up, ultrasound, or biopsy are not indicated for BI-RADS 2 findings. 1
Exception—if palpable correlate unclear: If a woman has a palpable finding and correlation between the BI-RADS 2 mammographic finding and the clinical finding is uncertain, targeted ultrasound may be performed to ensure the benign mammographic finding truly explains the palpable concern. 3 However, if the benign mammographic finding definitively correlates with the palpable area, no ultrasound is necessary. 3
Critical Distinction from BI-RADS 3
This differs fundamentally from BI-RADS 3 (probably benign), which requires short-interval follow-up at 6 months, then every 6-12 months for 1-2 years due to a <2% malignancy risk. 3, 1, 4 BI-RADS 2 findings have absolute certainty of benignity and require no surveillance beyond routine screening. 1
Common Pitfall to Avoid
Do not confuse BI-RADS 2 with BI-RADS 0 (incomplete assessment). BI-RADS 0 requires additional imaging evaluation before any management decision can be made, whereas BI-RADS 2 is a complete and definitive benign assessment. 1